Latin America Scar Treatment Market

Latin America Scar Treatment Market Size (2022 to 2027)

As per our research report, the Latin America Scar Treatment Market was valued at USD 3.00 billion in 2022. It is projected to reach USD 5.18 billion by 2027, growing at a CAGR of 11.54%.

Treatment by surgery can be effective as it provides benefits like changing the width or shape of the scar, changing its position, and releasing a tight scar close to the joint to improve joint movement. In addition, some facial scars can be covered by using cosmetic camouflage. 

Technological advancements and increasing appearance consciousness are the major factors driving the scar treatment market. As a result, there is an increase in the use of silicon-based products for the prevention and treatment of scars. Silicon sheets have gained popularity in the market as they protect the scar from moisture and infection.

The Latin American scar treatment market is expected to be driven by the increase in the number of road accidents in the region which is due to the lack of road safety that results in 130,000 fatalities with 6 million injuries per year, for instance, in 2015, in this region, the road traffic fatality rate was 19.2 percent per 100,000 people, which is the primary factor that is driving the demand for the treatment in the market.

Also, the initiatives and funding from the government and non-government to raise awareness about the treatment availability and the medications are driving the market growth. Furthermore, the increase in new developments and technological innovations for more advancements in scar treatment and government policies are also facilitating the growth of the scar treatment market in the Latin American region.

However, increase in the high costs of treatment, products, and procedures as more than 2- 3 sessions depending upon the type of skin and severity of the condition; also, the lack of skilled and trained individuals to handle the equipment and adequately treat the scar can hinder the growth of the market. In addition, due to an increase in the side effects of some therapies, as these treatment uses light and heat to treat the damaged cells, people experience side effects such as infections that affect the market growth of the scar treatment.

This research report on the Latin American Scar Treatment Market has been segmented and sub-segmented into the following categories:

By Treatment Type:

• Topical treatment
  • Creams
  • Oils
  • Gels
• Gel Sheets
  • Surface Treatment
  • Dermabrasion
  • Chemical Peeling
  • Cryosurgery
• Laser Treatment
• Injectable Treatment
  • Tissue Fillers
  • Steroid Injections
• Invasive Surgical Treatment

By Scar Type:

• Keloid and Hypertrophic Scars
• Contracture Scars
• Acne Scars
• Stretch Scars
• Post-Surgical Scars

By End User:

• Hospitals
• private clinics
• pharmacies & drug stores
• E-Commerce

By Country:

• Brazil
• Mexico
• Argentina
• Chile
• Rest of Latin America

Geographically, the Latin American region is expected to witness a promising share in the global scar treatment market during the forecast period. The market growth is attributed to the increasing number of road accidents, technological advancements, and the rising popularity and awareness of plastic surgery. 

The Brazilian scar treatment market is expected to grow at a promising rate during the forecast period. It is one of the most popular countries for scar treatment. Furthermore, the increase in the research and development activities for developing a new and advanced treatment for burns and scars with good medical facilities is increasing the market growth for scar treatment. 

Other countries, such as Mexico and Argentina, are expected to showcase lucrative growth rates due to the initiatives and raising awareness about the treatment available in the market. With the help of government and non-government funding, stringent policies are estimated to drive market growth.

KEY MARKET PLAYERS:

A few of the prominent companies operating in the Latin American Scar Treatment Market profiled in the report are Oculus Innovative Sciences Inc., Smith & Nephew PLC, Nutramarks Inc, Merz Inc, Enaltus LLC, CCA Industries Inc., Cynosure IncLumenis, Syneron Medical Ltd, Mölnlycke Health Care, Avita Medical Limited, Pacific World Corporation, Shanghai Fosun Pharmaceuticals Ltd, AC. Alma Lasers, Valeant Pharmaceuticals International Inc., and Beijing Toplaser Technology Company Limited.